Category: Cardiac Implants
Boston Scientific touts the 1st commercial implantations of its Watchman anti-stroke heart implant.
Shares of Boston Scientific jump today after the FDA approves its Watchman anti-stroke device.
Investors sent shares of Boston Scientific (NYSE:BSX) up nearly 4% today after the medical device company said the FDA approved its long-delayed Watchman anti-stroke device.
A retrospective analysis of St. Jude Medical's CardioMEMS HF implantable heart monitor shows it helps reduce death and hospitalization rates for heart failure patients.
Six years after an FDA panel 1st recommended approval, the safety watchdog grants pre-market approval to Boston Scientific's Watchman anti-stroke cardiac implant.
Medtronic touts a real-world study of its Reveal Linq insertable cardiac monitor for detecting atrial fibrillation and says a separate analysis shows that long-term implanted cardiac monitoring is cost-effective.
Neovasc reports positive data from a study of its stent-like device to treat refractory angina were published in the New England Journal of Medicine.
Neovasc (NYSE:NVC) said its device to treat refractory angina – implanted much like a coronary stent – met the endpoints in a clinical trial involving 104 patients.
SynCardia gains the FDA's O.K. to test its artificial heart as a permanent implant in 19 patients.
SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients.